Editorial Board

Editorial Board

Editor-in-Chief
Prof Pedro Romero, Ludwig Center for Cancer Research, Switzerland

Section Editors
Basic tumor immunology
Prof Cornelis JM Melief, ISA Therapeutics BV, Netherlands
Case reports
Prof Alfred Zippelius, University Hospital Basel, Switzerland
Clinical trials monitor
Dr Leisha Emens, Johns Hopkins University, USA
Clinical/translational cancer immunotherapy
Dr F Stephen Hodi, Dana-Farber Cancer Institute, USA
Commentary/editorials
Dr Christian Capitini, University of Wisconsin Madison, USA
Guidelines and Consensus Statements
Dr Robert L. Ferris, University of Pittsburgh, USA
Immunotherapy biomarkers
Dr Lisa H Butterfield, University of Pittsburgh, USA
Reviews
Prof Thomas F Gajewski, University of Chicago, USA
Dr Per Thor Straten,  Center for Cancer Immune Therapy, Denmark

Associate Editors
Basic tumor immunology
Dr Scott I Abrams, Roswell Park Cancer Institute, USA
Prof Paul A Antony, University of Maryland, USA
Dr Timothy NJ Bullock, University of Virginia, USA
Prof Gennaro Ciliberto, IRCCS Istituto Nazionale Tumori, Italy
Prof Michael A Curran, MD Anderson Cancer Center, USA
Dr Madhav V Dhodapkar, Yale University, USA
Dr Dmitry I Gabrilovich, The Wistar Institute, USA
Dr Norman M Greenberg, NMG Scientific, USA
Prof Elizabeth A Grimm, MD Anderson Cancer Center, USA
Dr Arthur A Hurwitz, National Cancer Institute, USA
Dr Masahisa Jinushi, Hokkaido University, Japan
Dr Michael H Kershaw, Peter MacCallum Cancer Center, Australia
Prof Khashayarsha Khazaie, Northwestern University, USA
Dr Christopher A Klebanoff, National Cancer Institute, USA
Dr Michelle Krogsgaard, New York University, USA
Dr Jeffrey S Munn, Gerogia Regents University, USA
Dr Pamela S Ohashi, Ontario Cancer Institute, Canada
Dr Willem Overwijk, MD Anderson Cancer Institute, USA
Dr Maria Rescigno, European Institute of Oncology, Italy
Dr Nicholas P Restifo, National Cancer Institute, USA
Dr Sjoerd H Van der Burg, Leiden University Medical Center, Netherlands
Dr Andrew D Weinberg, Earle A. Chiles Research Institute, USA
Case reports
Dr Djordje Atanackovic, University of Utah, USA
Dr Jack Bui, University of California San Diego, USA
Dr Richard D. Carvajal, Columbia University Medical Center, USA
Dr Heinz Laubli, University Hospital Basel, Switzerland
Prof Andreas Mackensen, University Hospital Erlangen, Germany
Dr Olivier Michielin, University of Lausanne, Switzerland
Dr Hiroyoshi Nishikawa, National Cancer Center, Japan
Dr Max Topp, University of Würzburg, Germany
Dr Michael von Bergwelt-Baildon, University of Cologne, Germany
Dr Geoffrey R. Weiss, University of Virginia, USA
Dr Hassane Zarour, University of Pittsburgh, USA
Clinical trials monitor
Dr Stephen Ansell, Mayo Clinic, USA
Dr Jonathan Cebon, Ludwig Institute for Cancer Research, Australia
Dr Tai-Tsang Chen, Columbia University; BMS, USA
Dr Jolanda de Vries, Radboud University Nijmegen, Netherlands
Dr Silvia Formenti, Weill Cornell Medical College, USA
Dr Howard Kaufman, Rutgers Cancer Institute of New Jersey, USA
Dr Larry Kwak, City of Hope, USA
Dr Sherene Loi, Peter MacCallum Cancer Centre, Australia
Dr Kunle Odunsi, Roswell Park Cancer Institute, USA
Dr Michael Postow, Memorial Sloan-Kettering Cancer Center, USA
Prof Peter Schmid, Imperial College London, United Kingdom
Dr Hiroshi Shiku, Mie University Graduate School of Medicine, Japan
Dr Daniel Speiser, Ludwig Institute for Cancer Research, Switzerland
Dr Louis Weiner, Georgetown University Lombardi Cancer Center, USA
Dr Yi-Long Wu, Guangdong General Hospital and Academy of Medical Sciences, China
Dr Xiabo Ye, Johns Hopkins University School of Medicine, USA
Clinical/translational cancer immunotherapy
Dr Paolo A Ascierto, Istituto Nazionale Tumori Fondazione G. Pascale, Italy
Dr Ernest C Borden, The Cleveland Clinic Foundation, USA
Dr George Coukos, University of Lausanne, Switzerland
Dr Charles Drake, Johns Hopkins University, USA
Dr Robert L Ferris, University of Pittsburgh Cancer Institute, USA
Dr Lawrence Fong, University of California, San Francisco, USA
Dr Nancy M Hardy, University of Maryland, USA
Dr Kristen Hege, Celgene Corp, USA
Dr Elizabeth Jaffee, Johns Hopkins University, USA
Dr Pawel Kalinski, University of Pittsburgh, USA
Dr Yutaka Kawakami, Keio University School of Medicine, Japan
Dr Samir N Khleif, Georgia Regents University, USA
Dr Sylvia M Kiertscher, UCLA, USA
Dr Beatrix Kotlan, National Institute of Oncology, Hungary
Dr Ada M Kruisbeek, DCPrime, The Netherlands
Prof Alessandro Lugli, University of Bern, Switzerland
Dr Michele Maio, Azienda Ospedalieria Senese, Italy
Prof Ignacio Melero, Univerity of Navarra, Spain
Dr Michael A Morse, Duke University Medical Center, USA
Prof Giorgio Parmiani, Fondazione C.S. Raffaele Del Monte Tabor, Italy
Dr Anna C Pavlick, NYU Cancer Institute, USA
Dr Stanley Riddell, Fred Hutchinson Cancer Research Center, USA
Dr Padmanee Sharma, MD Anderson Cancer Center, USA
Prof Per Thor Straten, University Hospital Herlev, Denmark
Dr Jeffrey S Weber, H. Lee Moffitt Cancer Center, USA
Dr Cassian Yee, MD Anderson Cancer Center, USA
Commentary/editorials
Dr Ana Anderson, Harvard University, USA
Dr Sandra Demaria, New York University School of Medicine, USA
Prof Wolf-Hervé Fridman, Cordeliers Research Center, France
Prof Bryon D Johnson, Medical College of Wisconsin, USA
Dr Douglas McNeel, University of Wisconsin, USA
Dr William J Murphy, University of California, Davis, USA
Dr Gabriel Rabinovich, Instituto de Biologia y Medicina Experimental, Argentina
Dr William L Redmond, Earle A. Chiles Research Institute, USA
Prof Paul M Sondel, University of Wisconsin, USA
Guidelines and consensus statements
Prof Paulo A. Ascierto, Istituto Nazional Tumori-Fondazione 'G.Pascale', Italy
Dr Michael B. Atkins, Georgetown-Lombardi Comprehensive Cancer Center, USA
Dr Michael R. Bishop, University of Chicago, USA
Prof Michael Platten, Ruprecht-Karls University Heidelberg, Germany
Immunotherapy biomarkers
Dr Alessandra Cesano, Nanostring, Inc., USA
Dr Michael Kalos, Lilly Research Laboratories, USA
Dr Thomas Kleen, Epiontis GmbH, Germany
Dr Rejean Lapointe, Universite De Montreal, University Hospital (CRCHUM), Canada
Dr Laszlo Radvanyi, Lion Biotechnologies, USA
Dr Licia Rivoltini, Fondazione IRCCS Istituto Nazionale Tumori, Italy
Dr Kimberly A Shafer-Weaver, AstraZeneca, USA
Dr Craig L Slingluff, University of Virginia, USA
Dr Ena Wang, Sidra Medical and Research Center, USA
Dr Jianda Yuan, Merck & Co., USA
Reviews
Dr Michael B Atkins, Georgetown-Lombardi Comprehensive Care Center, USA
Dr Ira Mellman, Genentech, USA
Dr James J Mule, H. Lee Moffitt Comprehensive Cancer Center, USA

JITC logo

Advertisement